Loading...

Kristen Krysko, MD

Title(s)Clinical Fellow, Neurology
SchoolSchool of Medicine
Address1500 Owens Street
San Francisco CA 94158
Phone415-353-2069
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse Education and Training
    University of Toronto, Toronto, ON, CanadaFRCPC06/2017Neurology Residency
    University of Toronto, Toronto, ON, CanadaMD06/2012Medicine
    McMaster University, Hamilton, ON, CanadaBSc06/2008Biology and Psychology

    Collapse Overview 
    Collapse Overview
    I started as a Multiple Sclerosis Clinical Research Fellow at UCSF in July 2017, after completing residency in Neurology at the University of Toronto in June 2017. I have a strong interest in clinical research related to multiple sclerosis, and my research mentors at UCSF include Dr. Waubant and Dr. Graves. My research interests include identifying modifiable risk factors for MS and interventions targeted at these, clinical trials of disease modifying therapies (DMTs), the impact of pregnancy on those with MS and MS management during pregnancy, and pediatric onset MS. Other areas of interest include studying treatment of fatigue in MS.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial. Lancet Neurol. 2020 Nov 23. Nourbakhsh B, Revirajan N, Morris B, Cordano C, Creasman J, Manguinao M, Krysko K, Rutatangwa A, Auvray C, Aljarallah S, Jin C, Mowry E, McCulloch C, Waubant E. PMID: 33242419.
      View in: PubMed   Mentions:    Fields:    
    2. Biosensor vital sign detects multiple sclerosis progression. Ann Clin Transl Neurol. 2020 Nov 19. Krysko KM, Akhbardeh A, Arjona J, Nourbakhsh B, Waubant E, Antoine Gourraud P, Graves JS. PMID: 33211403.
      View in: PubMed   Mentions:    Fields:    
    3. Ocrelizumab exposure in the second trimester of pregnancy without neonatal B-cell depletion. Mult Scler Relat Disord. 2020 Oct; 45:102398. Rolfes M, Rutatangwa A, Waubant E, Krysko KM. PMID: 32707531.
      View in: PubMed   Mentions: 1     Fields:    
    4. Sex effects across the lifespan in women with multiple sclerosis. Ther Adv Neurol Disord. 2020; 13:1756286420936166. Krysko KM, Graves JS, Dobson R, Altintas A, Amato MP, Bernard J, Bonavita S, Bove R, Cavalla P, Clerico M, Corona T, Doshi A, Fragoso Y, Jacobs D, Jokubaitis V, Landi D, Llamosa G, Longbrake EE, Maillart E, Marta M, Midaglia L, Shah S, Tintore M, van der Walt A, Voskuhl R, Wang Y, Zabad RK, Zeydan B, Houtchens M, Hellwig K. PMID: 32655689.
      View in: PubMed   Mentions:
    5. Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations. Mult Scler. 2020 Jun 19; 1352458520932798. Ghezzi A, Banwell B, Bar-Or A, Chitnis T, Dale RC, Gorman M, Kornek B, Krupp L, Krysko KM, Nosadini M, Rostasy K, Salzer J, Schreiner T, Tenembaum S, Waubant E. PMID: 32552353.
      View in: PubMed   Mentions:    Fields:    
    6. Transfer of monoclonal antibodies into breastmilk in neurologic and non-neurologic diseases. Neurol Neuroimmunol Neuroinflamm. 2020 07; 7(4). LaHue SC, Anderson A, Krysko KM, Rutatangwa A, Dorsey MJ, Hale T, Mahadevan U, Rogers EE, Rosenstein MG, Bove R. PMID: 32461351.
      View in: PubMed   Mentions: 2     Fields:    
    7. Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis. Ann Neurol. 2020 07; 88(1):42-55. Krysko KM, Graves JS, Rensel M, Weinstock-Guttman B, Rutatangwa A, Aaen G, Belman A, Benson L, Chitnis T, Gorman M, Goyal MS, Harris Y, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waltz M, Casper TC, Waubant E. PMID: 32267005.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Association Between Breastfeeding and Postpartum Multiple Sclerosis Relapses: A Systematic Review and Meta-analysis. JAMA Neurol. 2020 Mar 01; 77(3):327-338. Krysko KM, Rutatangwa A, Graves J, Lazar A, Waubant E. PMID: 31816024.
      View in: PubMed   Mentions: 3     Fields:    
    9. Novel MS vital sign: multi-sensor captures upper and lower limb dysfunction. Ann Clin Transl Neurol. 2020 03; 7(3):288-295. Akhbardeh A, Arjona JK, Krysko KM, Nourbakhsh B, Gourraud PA, Graves JS. PMID: 32101388.
      View in: PubMed   Mentions:    Fields:    
    10. Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions. Neurol Neuroimmunol Neuroinflamm. 2020 01; 7(1). Krysko KM, LaHue SC, Anderson A, Rutatangwa A, Rowles W, Schubert RD, Marcus J, Riley CS, Bevan C, Hale TW, Bove R. PMID: 31719115.
      View in: PubMed   Mentions: 5     Fields:    
    11. Telomere Length Is Associated with Disability Progression in Multiple Sclerosis. Ann Neurol. 2019 11; 86(5):671-682. Krysko KM, Henry RG, Cree BAC, Lin J, Caillier S, Santaniello A, Zhao C, Gomez R, Bevan C, Smith DL, Stern W, Kirkish G, Hauser SL, Oksenberg JR, Graves JS. PMID: 31486104.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    12. A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children. Mult Scler Relat Disord. 2019 Oct; 35:50-54. Manguinao M, Krysko KM, Maddike S, Rutatangwa A, Francisco C, Hart J, Chong J, Graves JS, Waubant E. PMID: 31319355.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    13. Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US. Neurology. 2018 11 06; 91(19):e1778-e1787. Krysko KM, Graves J, Rensel M, Weinstock-Guttman B, Aaen G, Benson L, Chitnis T, Gorman M, Goyal M, Krupp L, Lotze T, Mar S, Rodriguez M, Rose J, Waltz M, Charles Casper T, Waubant E. PMID: 30333163.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    14. Temporal trends in multiple sclerosis prevalence and incidence in a large population. Neurology. 2018 04 17; 90(16):e1435-e1441. Rotstein DL, Chen H, Wilton AS, Kwong JC, Marrie RA, Gozdyra P, Krysko KM, Kopp A, Copes R, Tu K. PMID: 29549225.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    15. Recurrent Alternate-Sided Homonymous Hemianopia Due to Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-Like Episodes (MELAS): A Case Report. Neuroophthalmology. 2017 Feb; 41(1):30-34. Krysko KM, Sundaram AN. PMID: 28228835.
      View in: PubMed   Mentions:
    16. Quality of Life, Cognition and Mood in Adults with Pediatric Multiple Sclerosis. Can J Neurol Sci. 2016 May; 43(3):368-74. Krysko KM, O'Connor P. PMID: 26795374.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    17. Identifying individuals with multiple sclerosis in an electronic medical record. Mult Scler. 2015 Feb; 21(2):217-24. Krysko KM, Ivers NM, Young J, O'Connor P, Tu K. PMID: 24948683.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    18. The toronto observational study of natalizumab in multiple sclerosis. Can J Neurol Sci. 2011 May; 38(3):422-8. Krysko KM, O'Connor PW. PMID: 21515500.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    19. A threat-detection advantage in those with autism spectrum disorders. Brain Cogn. 2009 Apr; 69(3):472-80. Krysko KM, Rutherford MD. PMID: 19036491.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    20. Eye direction, not movement direction, predicts attention shifts in those with autism spectrum disorders. J Autism Dev Disord. 2008 Nov; 38(10):1958-65. Rutherford MD, Krysko KM. PMID: 18521729.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    21. The use of aftereffects in the study of relationships among emotion categories. J Exp Psychol Hum Percept Perform. 2008 Feb; 34(1):27-40. Rutherford MD, Chattha HM, Krysko KM. PMID: 18248138.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    Kristen's Networks
    Concepts (77)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (18)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑